Literature DB >> 8280690

Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.

P Esser1, K Heimann, P Wiedemann.   

Abstract

Macrophages have long been known to play a major role in the pathogenesis of proliferative vitreoretinal disorders. Using the monoclonal antibodies EBM11 (pan macrophage), 27E10 (early inflammatory stage marker), and RM3/1 (healing phase marker), different subpopulations of macrophages were differentiated in surgically removed membranes from patients with macular pucker (n = 6), proliferative vitreoretinopathy (PVR) following rhegmatogenous retinal detachment (n = 11), traumatic PVR (n = 19), and proliferative diabetic retinopathy (PDR) (n = 11). Macrophages were predominantly found in traumatic PVR and PDR. Some healing phase (RM3/1) macrophages were detected in all disease entities. Inflammatory stage macrophages (positive staining for 27E10) could not be detected in PVR following rhegmatogenous retinal detachment and idiopathic macular pucker. In traumatic PVR inflammatory stage macrophages were associated with a short history of disease whereas in PDR all types of macrophages could be detected regardless of clinical history and duration of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280690      PMCID: PMC504635          DOI: 10.1136/bjo.77.11.731

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.

Authors:  E P Chen; U H Steinhorst; G P Samsa; P T Saloupis; D L Hatchell
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-06       Impact factor: 4.799

2.  Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies.

Authors:  W A Franklin; D Y Mason; K Pulford; B Falini; E Bliss; K C Gatter; H Stein; L C Clarke; J O McGee
Journal:  Lab Invest       Date:  1986-03       Impact factor: 5.662

3.  The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.

Authors:  D B Chandler; G Rozakis; E de Juan; R Machemer
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

4.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

5.  Influence of various detachment procedures on the functional state of cultured murine macrophages.

Authors:  U Malorny; C Neumann; C Sorg
Journal:  Immunobiology       Date:  1981       Impact factor: 3.144

6.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

7.  Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study.

Authors:  P S Hiscott; I Grierson; D McLeod
Journal:  Br J Ophthalmol       Date:  1985-11       Impact factor: 4.638

8.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

Authors:  Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-12       Impact factor: 5.258

9.  Retinal wound healing. Cellular activity at the vitreoretinal interface.

Authors:  B Miller; H Miller; R Patterson; S J Ryan
Journal:  Arch Ophthalmol       Date:  1986-02

10.  Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.

Authors:  Z Werb
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  32 in total

1.  Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  Y Mitamura; S Takeuchi; A Matsuda; Y Tagawa; Y Mizue; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Retinal detachment after posterior segment intraocular foreign body injuries.

Authors:  A M El-Asrar; S A Al-Amro; N M Khan; D Kangave
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

3.  Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases.

Authors:  A J Augustin; F H Grus; F Koch; M Spitznas
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 5.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

6.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 7.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

Review 8.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

Review 9.  Diverse roles of macrophages in intraocular neovascular diseases: a review.

Authors:  Ye-Di Zhou; Shigeo Yoshida; Ying-Qian Peng; Yoshiyuki Kobayashi; Lu-Si Zhang; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

10.  Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.

Authors:  William S Wright; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.